Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110996894 | 11099689 | 4 | F | 2015 | 20160817 | 20150508 | 20160825 | EXP | IT-009507513-1504ITA024048 | MERCK | 55.00 | YR | M | Y | 93.00000 | KG | 20160825 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110996894 | 11099689 | 1 | PS | REBETOL | RIBAVIRIN | 1 | Oral | UNK, QD | 20903 | CAPSULE | QD | ||||||||
| 110996894 | 11099689 | 2 | SS | RITONAVIR. | RITONAVIR | 1 | Oral | UNK, QD | 14-006453 | 0 | QD | ||||||||
| 110996894 | 11099689 | 3 | SS | OMBITASVIR | OMBITASVIR | 1 | UNK | 0 | |||||||||||
| 110996894 | 11099689 | 4 | SS | ABT-450 | PARITAPREVIR | 1 | UNK | 0 | |||||||||||
| 110996894 | 11099689 | 5 | SS | DASABUVIR | DASABUVIR | 1 | UNK, BID | 0 | BID | ||||||||||
| 110996894 | 11099689 | 6 | C | KANRENOL | CANRENOATE POTASSIUM | 1 | Oral | UNK, 1 DOSE UNIT | 0 | TABLET | |||||||||
| 110996894 | 11099689 | 7 | C | LASITONE | FUROSEMIDESPIRONOLACTONE | 1 | Oral | UNK | 0 | ||||||||||
| 110996894 | 11099689 | 8 | C | NORMIX | RIFAXIMIN | 1 | Oral | UNK | 0 | ||||||||||
| 110996894 | 11099689 | 9 | C | LUCEN (esomeprazole sodium) | 2 | UNK | 0 | ||||||||||||
| 110996894 | 11099689 | 10 | C | KONAKION | PHYTONADIONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110996894 | 11099689 | 1 | Chronic hepatitis C |
| 110996894 | 11099689 | 2 | Chronic hepatitis C |
| 110996894 | 11099689 | 3 | Chronic hepatitis C |
| 110996894 | 11099689 | 4 | Chronic hepatitis C |
| 110996894 | 11099689 | 5 | Chronic hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110996894 | 11099689 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110996894 | 11099689 | Arthralgia | |
| 110996894 | 11099689 | Asthenia | |
| 110996894 | 11099689 | Hepatic encephalopathy | |
| 110996894 | 11099689 | Lethargy | |
| 110996894 | 11099689 | Nausea | |
| 110996894 | 11099689 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110996894 | 11099689 | 1 | 20150316 | 0 | ||
| 110996894 | 11099689 | 2 | 20150316 | 0 | ||
| 110996894 | 11099689 | 3 | 20150316 | 0 | ||
| 110996894 | 11099689 | 4 | 20150316 | 0 | ||
| 110996894 | 11099689 | 5 | 20150316 | 0 | ||
| 110996894 | 11099689 | 6 | 20130101 | 0 | ||
| 110996894 | 11099689 | 7 | 20130101 | 0 | ||
| 110996894 | 11099689 | 8 | 20130101 | 0 | ||
| 110996894 | 11099689 | 9 | 20130101 | 0 | ||
| 110996894 | 11099689 | 10 | 20130101 | 0 |